HCA Healthcare (NYSE: HCA) director Chidsey granted 809 restricted share units

Rhea-AI Filing Summary

CHIDSEY JOHN reported acquisition or exercise transactions in this Form 4 filing.

HCA Healthcare director John Chidsey reported an equity award of 809 restricted share units of common stock. These units were granted as part of his annual director compensation, including 509 units from an annual director equity award and 300 units received in lieu of an annual cash retainer.

Following this grant, Chidsey directly holds 1,305 shares of HCA Healthcare common stock. In addition, 25 shares are held indirectly by his spouse, and 3 shares are held in a fully managed account over which he does not have investment authority and for which he disclaims beneficial ownership except for any pecuniary interest.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider CHIDSEY JOHN

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	809	$0.00	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 1,305 shares (Direct, null); Common Stock — 3 shares (Indirect, By managed account)

Footnotes (1)

1. Represents common stock underlying 509 restricted share units attributable to an annual director equity award and 300 restricted share units received in lieu of an annual cash retainer for service as a director. The restricted share units shall vest on the sooner of the date of the 2027 annual shareholders' meeting of HCA Healthcare, Inc. or the first anniversary of the grant date. The shares reported herein are held in a fully managed account over which the Reporting Person does not have any investment authority. The Reporting Person disclaims beneficial ownership of the shares reported herein except to the extent of his pecuniary interest therein.

Key Figures

Restricted share units granted: 809 units Direct holdings after grant: 1,305 shares Spouse-held shares: 25 shares +3 more

6 metrics

Restricted share units granted 809 units Equity award reported on Form 4

Direct holdings after grant 1,305 shares Common stock directly held after transaction

Spouse-held shares 25 shares Indirect ownership by spouse

Managed account shares 3 shares Held in fully managed account with no investment authority

Annual director equity RSUs 509 units Restricted share units from annual director equity award

RSUs in lieu of cash retainer 300 units Units received instead of annual cash retainer

Key Terms

restricted share units, annual director equity award, annual cash retainer, managed account, +1 more

5 terms

restricted share units financial

"Represents common stock underlying 509 restricted share units attributable to an annual director equity award"

Restricted share units (RSUs) are a promise from a company to give an employee or service provider actual shares or cash equal to the shares after certain conditions are met, typically staying with the company for a set time or hitting performance targets. Think of them like a time-locked gift card that becomes usable only after you’ve earned it. For investors, RSUs matter because they align employee incentives with company performance and can increase the number of shares outstanding over time, diluting existing ownership and affecting earnings per share.

annual director equity award financial

"restricted share units attributable to an annual director equity award and 300 restricted share units received in lieu"

annual cash retainer financial

"300 restricted share units received in lieu of an annual cash retainer for service as a director"

managed account financial

"The shares reported herein are held in a fully managed account over which the Reporting Person does not have any investment authority"

pecuniary interest financial

"The Reporting Person disclaims beneficial ownership of the shares reported herein except to the extent of his pecuniary interest therein"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

CHIDSEY JOHN

(Last) (First) (Middle)

ONE PARK PLAZA

(Street)

NASHVILLE TENNESSEE 37203

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
HCA Healthcare, Inc. [ HCA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/28/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/28/2026		A(1)		809	A	$0	1,305	D
Common Stock								3	I	By managed account(2)
Common Stock								25	I	By Spouse(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents common stock underlying 509 restricted share units attributable to an annual director equity award and 300 restricted share units received in lieu of an annual cash retainer for service as a director. The restricted share units shall vest on the sooner of the date of the 2027 annual shareholders' meeting of HCA Healthcare, Inc. or the first anniversary of the grant date.

2. The shares reported herein are held in a fully managed account over which the Reporting Person does not have any investment authority. The Reporting Person disclaims beneficial ownership of the shares reported herein except to the extent of his pecuniary interest therein.

	/s/ Kevin A. Ball, Attorney-in-Fact	04/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)